[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES517333A0 - Procedimientos para preparar derivados piridazinona. - Google Patents

Procedimientos para preparar derivados piridazinona.

Info

Publication number
ES517333A0
ES517333A0 ES517333A ES517333A ES517333A0 ES 517333 A0 ES517333 A0 ES 517333A0 ES 517333 A ES517333 A ES 517333A ES 517333 A ES517333 A ES 517333A ES 517333 A0 ES517333 A0 ES 517333A0
Authority
ES
Spain
Prior art keywords
piridazinone
procedures
derivatives
preparing
preparing piridazinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES517333A
Other languages
English (en)
Other versions
ES8404340A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES8404340A1 publication Critical patent/ES8404340A1/es
Publication of ES517333A0 publication Critical patent/ES517333A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES517333A 1981-11-12 1982-11-12 Procedimientos para preparar derivados piridazinona. Granted ES517333A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8134176 1981-11-12

Publications (2)

Publication Number Publication Date
ES8404340A1 ES8404340A1 (es) 1984-04-16
ES517333A0 true ES517333A0 (es) 1984-04-16

Family

ID=10525837

Family Applications (1)

Application Number Title Priority Date Filing Date
ES517333A Granted ES517333A0 (es) 1981-11-12 1982-11-12 Procedimientos para preparar derivados piridazinona.

Country Status (12)

Country Link
US (1) US4493835A (es)
EP (1) EP0086301A1 (es)
JP (1) JPS58131973A (es)
AU (1) AU9000682A (es)
DK (1) DK487082A (es)
ES (1) ES517333A0 (es)
FI (1) FI823895L (es)
GR (1) GR77782B (es)
IL (1) IL67098A0 (es)
NO (1) NO823765L (es)
PT (1) PT75828A (es)
ZA (1) ZA827641B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052442B1 (en) * 1980-11-14 1985-09-11 Imperial Chemical Industries Plc Heterocyclic compounds
US4657906A (en) * 1982-06-05 1987-04-14 Smith Kline & French Laboratories Ltd. Heterocyclic compounds having inotropic activity
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
GB8328907D0 (en) * 1983-10-28 1983-11-30 Smith Kline French Lab Chemical compounds
GB8332313D0 (en) * 1983-12-02 1984-01-11 Smith Kline French Lab Chemical compounds
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
US4898862A (en) * 1986-03-20 1990-02-06 Sankyo Company Limited 1,2,4-triazinone derivatives, their preparation and use
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
EP3661917B1 (en) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
BR112021013345A2 (pt) * 2019-02-01 2021-09-14 Bayer Aktiengesellschaft Compostos de 1,2,4-triazin-3(2h)-ona para o tratamento de doenças hiperproliferativas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3377345A (en) * 1966-09-23 1968-04-09 Dow Chemical Co Substituted 3, 4, 5, 6-tetrahydro-2h-1, 3, 4-oxadiazin-2-one compounds and method ofpreparation thereof
FR8169M (es) * 1967-05-17 1970-08-31
US3946010A (en) * 1975-04-09 1976-03-23 E. R. Squibb & Sons, Inc. 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
US4097671A (en) * 1975-08-28 1978-06-27 General Electric Company Dihydrooxadiazinones and method for making
US4097425A (en) * 1975-08-28 1978-06-27 General Electric Company Thermoplastic formable blends, a foaming method and products made thereby
US4105848A (en) * 1976-12-27 1978-08-08 General Electric Company Process for the production of dihydrooxadiazinone compounds
EP0052442B1 (en) * 1980-11-14 1985-09-11 Imperial Chemical Industries Plc Heterocyclic compounds

Also Published As

Publication number Publication date
NO823765L (no) 1983-05-13
PT75828A (en) 1982-12-01
FI823895L (fi) 1983-05-13
EP0086301A1 (en) 1983-08-24
GR77782B (es) 1984-09-25
US4493835A (en) 1985-01-15
ES8404340A1 (es) 1984-04-16
AU9000682A (en) 1983-05-19
JPS58131973A (ja) 1983-08-06
IL67098A0 (en) 1983-02-23
FI823895A0 (fi) 1982-11-12
DK487082A (da) 1983-05-13
ZA827641B (en) 1983-09-28

Similar Documents

Publication Publication Date Title
ES514016A0 (es) Procedimiento para preparar derivados de n-fenilpirazol.
ES507715A0 (es) Procedimiento para preparar derivados de 1-sulfo-2-oxoazetidina .
ES516588A0 (es) Procedimiento para preparar derivados de piridona.
ES517332A0 (es) Procedimiento para preparar derivados de feniltiadiazinona.
ES514796A0 (es) Procedimiento para preparar compuestos tetrakisazoicos.
ES523733A0 (es) Procedimiento para preparar acilanilidas.
MX158198A (es) Procedimiento para preparar derivados de amidinopiperidina
ES512295A0 (es) Procedimiento para preparar derivados de piridina.
ES516717A0 (es) Procedimiento para la obtencion de derivados de trifluormetil-fenoxifenil-silicio.
ES517333A0 (es) Procedimientos para preparar derivados piridazinona.
ES519402A0 (es) Procedimiento para preparar derivados de guanidina.
ES510258A0 (es) Procedimiento para preparar derivados de quanadina.
ES506842A0 (es) Procedimiento para preparar derivados 3-aminopropoxifenili- cos.
ES509044A0 (es) Procedimiento para preparar derivados de fenilsulfonilurea sustituidos.
ES508803A0 (es) Procedimiento para la obtencion de derivados de sisomicina.
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES527945A0 (es) Procedimiento para preparar derivados de bencilcarbamoilpiridina.
MX6975E (es) Procedimiento para preparar s,s-dialquil-fosforoditioatos de o-alquilo
ES511317A0 (es) Procedimiento para preparar derivados de imidazol.
ES511911A0 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
ES509734A0 (es) Procedimiento para preparar derivados de benzotiadiazol-amina.
ES510584A0 (es) Procedimiento para preparar derivados de guanidina.
ES525333A0 (es) Procedimiento para preparar derivados de sulfamoilbenzofenona.
ES512397A0 (es) "procedimiento para preparar derivados de nicotinoilbenzoguanamina".
ES516880A0 (es) Procedimiento de preparar derivados de p-acilaminofenol.